Association of the ala54-thr polymorphism in the intestinal fatty acid-binding protein with 2-h postchallenge insulin levels in the framingham offspring study

Diabetes Care

Volumn 24, Issue 7, 2001, Pages 1161-1166

  Galluzzi, Jennifer R ^a   Adrienne Cupples, L ^b   Meigs, James B ^c   Wilson, Peter W F ^d   Schaefer, Ernst J ^a   Ordovas, Jose M ^a  

^a TUFTS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; APOLIPOPROTEIN E; CARRIER PROTEIN; CHOLESTEROL; DNA; FABP2 PROTEIN, HUMAN; FABP2 PROTEIN, MOUSE; FABP7 PROTEIN, HUMAN; FATTY ACID; FATTY ACID BINDING PROTEIN; GLYCOSYLATED HEMOGLOBIN; INSULIN; THREONINE; TRIACYLGLYCEROL; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; DRINKING BEHAVIOR; ESTROGEN THERAPY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PROSPECTIVE STUDY; RISK FACTOR; SECRETION; SEXUAL DEVELOPMENT; SMOKING; UNITED STATES;

ALANINE; ALCOHOL DRINKING; APOLIPOPROTEINS E; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CHOLESTEROL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DNA; ESTROGEN REPLACEMENT THERAPY; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; INSULIN; MALE; MASSACHUSETTS; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; SMOKING; THREONINE; TRIGLYCERIDES; TUMOR SUPPRESSOR PROTEINS;

EID: 0035403711     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.7.1161     Document Type: Article

References (13)

1. Randle PJ, Hales CM, Garland PB, Newsholme EA: The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785-789, 1963
2. Lowe JB, Sacchettini JC, Laposata M, McQuillan JJ, Gordon JI: Expression of rat intestinal fatty acid-binding protein in Escherichia coli: purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J Biol Chem 262:5931-5937, 1987
3. McArthur MJ, Atshaves BP, Frolov A, Foxworth WD, Kier AB, Schroeder F: Cellular uptake and intracellular trafficking of long chain fatty acids. J Lipid Res 40: 1371-1383, 1999
4. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, Mochizuki H, Bennett PH, Bogardus C, Prochazka M: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95:1281-1287, 1995
5. Baier LJ, Bogardus C, Sacchettini JC: A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J Biol Chem 271:10892-10896, 1996
6. Prochazka M, Lillioja S, Tait JF, Knowler WC, Mott DM, Spraul M, Bennett PH, Bogardus C: Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 42:514-519, 1993
7. Mitchell BD, Kammerer CM, O'Connell P, Harrison CR, Manire M, Shipman P, Moyer MP, Stern MP, Frazier ML: Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans. Diabetes 44:1046-1053, 1995
8. Yamada K, Yuan X, Ishiyama S, Koyama K, Ichikawa F, Koyanagi A, Koyama W, Nonaka K: Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 40:706-710, 1997
9. Boullu-Sanchis S, Lepretre F, Hedelin G, Donnet JP, Schaffer P, Froguel P, Pinget M: Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of the FABP2 polymorphism. Diabetes Metab 25:150-156, 1999
10. Humphreys P, McCarthy M, Tuomilehto J, Tuomilehto-Wolf E, Stratum I, Morgan R, Rees A, Owens D, Stengard J, Nissinen A, Hitman G, Turner RC, O'rahilly S: Chromosome 4q locus associated with insulin resistance in Pima Indians: studies in three European NIDDM populations. Diabetes 43:800-804, 1994
11. Hegele RA, Harris SB, Hanley AJ, Sadikian S, Connelly PW, Zinman B: Genetic variation of intestinal fatly acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 81:4334-4337, 1996
12. Stern MP, Mitchell BD, Blangero J, Reinhart L, Kammerer CM, Harrison CR, Shipman PA, O'Connell P, Frazier ML, MacCluer JW: Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes 45:563-568, 1996
13. Yagi T, Nishi S, Hinata SI, Murakami M, Yoshima T: A population association study of four candidate genes (hexokinase II, glucagon-like peptide-1 receptor, fatty acid binding proiein-2, and Apolipoprotein C-II) with type 2 diabetes and impaired glucose tolerance in Japanese subjects. Diabet Med 13:902-907, 1996